Hybrid molecules based on 1,3,5-triazine as potential therapeutics: A focused review
Parteek Prasher1,2, Mousmee Sharma1,3, Alaa A A Aljabali4
1UGC-Sponsored Centre for Advanced Studies, Department of Chemistry, Guru Nanak Dev University, Amritsar, India.
Abstract:
Majority of the representative drugs customarily interact with multiple targets manifesting unintended side effects. In addition, drug resistance and over expression of the cellular efflux-pumps render certain classes of drugs ineffective. With only a few innovative formulations in development, it is necessary to identify pharmacophores and novel strategies for creating new drugs. The conjugation of dissimilar pharmacophoric moieties to design hybrid molecules with an attractive therapeutic profile is an emerging paradigm in the contemporary drug development regime. The recent decade witnessed the remarkable biological potential of 1,3,5-triazine framework in the development of various chemotherapeutics. The appending of the 1,3,5-triazine nucleus to biologically relevant moieties has delivered exciting results. The present review focuses on 1,3,5-triazine based hybrid molecules in the development of pharmaceuticals.
Related Concept Videos
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Basicity of Heterocyclic Aromatic Amines
Diazonium Group Substitution: –OH and –H
Five-Membered Heterocyclic Aromatic Compounds: Overview
Aromatic Hydrocarbon Cations: Structural Overview
Removing one hydrogen from the intervening CH2 group...
Preparation of 1° Amines: Hofmann and Curtius Rearrangement Overview


